ASTRAZENECA PLC (AZN:NASDAQ)
$179.42 0.71 (0.3973%)
Analysed ASTRAZENECA PLC (AZN:NASDAQ) News Sources
AstraZeneca's Truqap Wins FDA Nod for Prostate Cancer Indication
15-06-2026
yahoo.com
EHA26: AstraZeneca battles Roche in untreated follicular lymphoma
15-06-2026
clinicaltrialsarena.com
AstraZeneca says AI is raising its odds where most drugs fail
16-06-2026
thestreet.com
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
16-06-2026
yahoo.com
FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris
16-06-2026
yahoo.com
Top Stock Reports for Applied Materials, GE & AstraZeneca
16-06-2026
yahoo.com
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
16-06-2026
yahoo.com
The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics
17-06-2026
yahoo.com
Big pharma taps UK playbook to pressure Europe on drug prices
17-06-2026
yahoo.com
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
17-06-2026
yahoo.com
What is the current price of ASTRAZENECA PLC (AZN:NASDAQ)?
The current price of ASTRAZENECA PLC (AZN:NASDAQ) is $179.42.
ASTRAZENECA PLC (AZN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASTRAZENECA PLC (AZN:NASDAQ) since the previous trading day is $0.71.
ASTRAZENECA PLC (AZN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASTRAZENECA PLC (AZN:NASDAQ) since the previous trading day is 0.3973%.
What is the most recent average sentiment score for ASTRAZENECA PLC (AZN:NASDAQ)?
The most recent average sentiment score for ASTRAZENECA PLC (AZN:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for ASTRAZENECA PLC (AZN:NASDAQ)?
The most recent sentiment for ASTRAZENECA PLC (AZN:NASDAQ) is .
SEC-8K** Filing Available For ASTRAZENECA PLC (AZN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.